May 14, 2013, 06.10 PM | Source: CNBC-TV18
One can hold Dr Reddys Laboratories, says Prakash Diwan, Chief Portfolio Strategist of Prakash Diwan's Wealth Circle, ECR.
Prakash Diwan (more)
Market Expert, prakashdiwan.in | Capital Expertise: Equity - Fundamental
He further added, "The best point is the valuations, I don’t think valuations are stretched as compared to Sun Pharma or a Cipla or a Lupin relatively. I think the investor should hold on. Wait for another 20-25 percent of an upside in the next 9 to 12 months if the investor is patient enough."
Nifty to remain weak and drag the markets down tod
It has launched the injection USP in the strengths
Under the terms of collaboration, DRL will commerc
Dr Reddy's Laboratories has been listed on Dow Jon
Dr Reddy's Laboratories today said it has launched